Abstract
In clinical practice, brachial blood pressure measurement remains the classical reference for identifying hypertension, but this has been challenged recently. Indeed, estimation of central aortic pressure has been shown to be a stronger predictor of coronary artery disease [1,2] and even brings new insights regarding the effect of different antihypertensive drugs, as documented in the Conduit Artery Function Evaluation (CAFE) study. CAFE is a sub-study of the large Anglo-Scandinavian Cardiac Outcomes trial (ASCOT) in which, despite the similar control of brachial blood pressure, aortic blood pressure was significantly lower in the amlodipine-perindopril arm compared to the betablocker-diuretic arm [3,4].
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
